Skip to main content

Advertisement

SpringerLink
Log in

Hepatitis C Treatment Cascade in a Federally Qualified Health Center

  • Original Paper
  • Published:
Journal of Community Health Aims and scope Submit manuscript

Abstract

Hepatitis C (HCV) care cascades have been described in diverse clinical settings, patient populations and countries, highlighting the steps in HCV care where improvements can be made and resources allocated. However, more research is needed to examine barriers to HCV treatment in rural, underserved populations and in Federally Qualified Health Centers (FQHCs). As part of a quality improvement (QI) project, this study aimed to describe and evaluate the HCV treatment cascade in an FQHC serving a large rural patient population in the Western United States. Standardized chart abstraction was utilized to aggregate data regarding patient demographics, the percentage of patients achieving each step in the treatment cascade, and relevant patient (i.e., viral load) and service variables (i.e., whether and when patients received treatment or medication). 389 patients were identified as having HCV and 86% were aware of their diagnosis. Fifty-five percent had their infection confirmed via viral load, 21% were staged for liver disease, 24% received a prescription for treatment, and 19% achieved cure. Compared to national data, the current regional sample had greater rates of diagnosis awareness and access to care, as well as sustained virologic response (SVR), but lower rates of viral load confirmation. Current findings suggest that rural patients living with HCV who receive care at FQHCs struggle to navigate the treatment cascade and achieve a cure, particularly with regard to infection confirmation, liver staging, and prescription. However, compared to national estimates, patients had greater rates of diagnosis awareness/treatment access and SVR.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. AASLD-IDSA. HCV guidance: Recommendations for testing, managing, and treating hepatitis C. Retrieved July 22, 2019 from https://www.hcvguidelines.org/sites/default/files/full-guidance-pdf/HCVGuidance_May_24_2018b.pdf

  2. Smith, B. D., Morgan, R. L., Beckett, G. A., Falck-Ytter, Y., Holtzman, D., & Ward, J. W. (2012). Hepatitis C virus testing of persons born during 1945-1965: Recommendations from the Centers for Disease Control and Prevention. Annals of Internal Medicine,157, 817–822. https://doi.org/10.7326/0003-4819-157-9-201211060-00529.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Yehia, B. R., Schranz, A. J., Umscheid, C. A., Lo Re, I. I. I., & Lo Re III, V. (2014). The treatment cascade for chronic Hepatitis C Virus infection in the United States: A systematic review and meta-analysis. PLoS ONE,9(7), 1–7.

    Google Scholar 

  4. Kattakuzhy, S., Gross, C., Emmanuel, B., et al. (2017). Expansion of treatment for hepatitis C virus infection by task shifting to community-based nonspecialist providers: A nonrandomized clinical trial. Annals of Internal Medicine,167(5), 311–318.

    Article  Google Scholar 

  5. Gardner, E. M., McLees, M. P., Steiner, J. T., Del Rio, C., & Burman, W. J. (2011). The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clinical Infectious Diseases,52(6), 793–800.

    Article  Google Scholar 

  6. Gvinjilia, L., Nasrullah, M., Sergeenko, D., et al. (2016). National progress toward hepatitis C elimination—Georgia, 2015–2016, MMWR. Morbidity and Mortality Weekly Report,65, 1132–1135.

    Article  Google Scholar 

  7. Janjua, N. Z., Kuo, M., Yu, A., et al. (2016). The population level cascade of care for hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC). EBioMedicine,12, 189–195.

    Article  Google Scholar 

  8. Wade, A. J., Macdonald, D. M., Doyle, J. S., et al. (2015). The cascade of care for an Australian community-based hepatitis C treatment service. PLoS ONE,10(11), e0142770.

    Article  Google Scholar 

  9. Cachay, E. R., Hill, L., Wyles, D., et al. (2014). The hepatitis C cascade of care among HIV infected patients: A call to address ongoing barriers to care. PLoS ONE,9(7), e102883.

    Article  Google Scholar 

  10. Mera, J., Vellozzi, C., Hariri, S., et al. (2016). Identification and clinical management of persons with chronic hepatitis C virus infection - Cherokee Nation, 2012-2015. MMWR Morbidity and Mortality Weekly Report,65(18), 461–466.

    Article  Google Scholar 

  11. Jonas, M. C., Rodriguez, C. V., Redd, J., Sloane, D. A., Winston, B. J., & Loftus, B. C. (2016). Streamlining screening to treatment: The hepatitis C cascade of care at Kaiser Permanente Mid-Atlantic States. Clinical Infectious Diseases,62(10), 1290–1296.

    Article  CAS  Google Scholar 

  12. Health Resources & Services Administration. (2018). Health services program. Retrieved July 22, 2019 from https://bphc.hrsa.gov/about/healthcenterfactsheet.pdf.

  13. Arora, S., Thornton, K., Murata, G., et al. (2011). Outcomes of treatment for hepatitis C virus infection by primary care providers. New England Journal of Medicine,364(23), 2199–2207.

    Article  CAS  Google Scholar 

  14. Camminati, C. W., Simha, A., Kolb, N. R., & Prasad, R. (2016). Intent to build hepatitis C treatment capacity within family medicine residencies: A nationwide survey of program directors: A CERA study. Family Medicine,48(8), 631–634.

    Google Scholar 

  15. Benjamini, Y., & Hochberg, Y. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society: Series B (Statistical Methodology),57(1), 289–300.

    Google Scholar 

  16. Younossi, Z. M., Stepanova, M., Afendy, M., et al. (2013). Knowledge about infection is the only predictor of treatment in patients with chronic hepatitis C. Journal of Viral Hepatitis,20, 550–555.

    Article  CAS  Google Scholar 

  17. Moorman, A. C., Gordon, S. C., Rupp, L. B., et al. (2013). Baseline characteristics and mortality among people in care for chronic viral hepatitis: The chronic hepatitis cohort study. Clinical Infectious Diseases,56, 40–50.

    Article  Google Scholar 

  18. Groessl, E. J., Liu, L., Ho, S. B., et al. (2012). National patterns and predictors of liver biopsy use for management of hepatitis C. Journal of Hepatology,57, 252–259.

    Article  Google Scholar 

  19. Kanwal, F., Schnitzler, M. S., Bacon, B. R., et al. (2010). Quality of care in patients with chronic hepatitis C virus infection: A cohort study. Annals of Internal Medicine,153, 231–239.

    Article  Google Scholar 

  20. Kanwal, F., Hoang, T., Chrusciel, T., et al. (2012). Process of care for hepatitis C infection is linked to treatment outcome and virologic response. Clinical Gastroenterology and Hepatology,10, 1270–1277.

    Article  Google Scholar 

  21. Lubega, S., Agbim, U., Surjadi, M., Mahoney, M., & Khalili, M. (2013). Formal hepatitis C education enhances HCV care coordination, expedites HCV treatment and improves antiviral response. Liver International,33, 999–1007.

    Article  CAS  Google Scholar 

  22. Falade-Nwulia, O., McAdams-Mahmoud, A., Irvin, R., et al. (2016). Primary care providers knowledge, attitude and practices related to hepatitis C screening and treatment in the oral direct acting antiviral agents era. Journal of Community Medicine and Health Education,6(5), 481.

    PubMed  Google Scholar 

  23. Zickmund, S. L., Brown, K. E., & Bielefeldt, K. (2007). A systematic review of provider knowledge of hepatitis C: Is it enough for a complex disease? Digestive Diseases and Sciences,52(10), 2550–2556.

    Article  Google Scholar 

  24. Institute for Healthcare Improvement. (2019). Age-friendly health systems: Guide to using the 4Ms in the care of older adults. Retrieved July 8, 2019 from http://www.ihi.org/Engage/Initiatives/Age-Friendly-Health-Systems/Documents/IHIAgeFriendlyHealthSystems_GuidetoUsing4MsCare.pdf.

Download references

Funding

This study did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors.

Author information

Authors and Affiliations

  1. Department of Family Medicine, Idaho State University, 921 S. 8th Ave. Stop, Pocatello, ID, 83209, USA

    David M. Hachey & John T. Holmes

  2. Department of Psychology, Idaho State University, Pocatello, ID, USA

    Nicki L. Aubuchon-Endsley

Authors
  1. David M. Hachey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John T. Holmes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nicki L. Aubuchon-Endsley
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David M. Hachey.

Ethics declarations

Conflict of interest

The authors declare no relevant conflicts of interest or financial relationships.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hachey, D.M., Holmes, J.T. & Aubuchon-Endsley, N.L. Hepatitis C Treatment Cascade in a Federally Qualified Health Center. J Community Health 45, 264–268 (2020). https://doi.org/10.1007/s10900-019-00736-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10900-019-00736-4

Keywords

Search

Navigation